These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 26431840

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monotherapy.
    Konstas AG, Boboridis KG, Kapis P, Marinopoulos K, Voudouragkaki IC, Panayiotou D, Mikropoulos DG, Pagkalidou E, Haidich AB, Katsanos A, Quaranta L.
    Adv Ther; 2017 Jan; 34(1):221-235. PubMed ID: 27913991
    [Abstract] [Full Text] [Related]

  • 3. Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study.
    Oddone F, Tanga L, Kóthy P, Holló G, VISIONARY Study Group.
    Adv Ther; 2020 Apr; 37(4):1436-1451. PubMed ID: 32072493
    [Abstract] [Full Text] [Related]

  • 4. A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components.
    Pfeiffer N, Traverso CE, Lorenz K, Saarela V, Liinamaa J, Uusitalo H, Astakhov Y, Boiko E, Ropo A, Preservative-free Tafluprost/Timolol Fixed Combination Study Group.
    Adv Ther; 2014 Dec; 31(12):1228-46. PubMed ID: 25447269
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of tafluprost 0.0015% and timolol maleate 0.5% fixed combination in patients with ocular hypertension or open-angle glaucoma.
    Lorenz K, Pfeiffer N.
    Expert Opin Pharmacother; 2014 Oct; 15(15):2255-62. PubMed ID: 25170534
    [Abstract] [Full Text] [Related]

  • 6. A comparison of country-level data from the VISIONARY study examining treatment outcomes with preservative-free tafluprost/timolol fixed-dose combination therapy.
    Holló G, Kirwan J, Lopez-Lopez F, Zimina M, Fassari C, Oddone F, VISIONARY Study Group.
    Curr Med Res Opin; 2022 Jul; 38(7):1189-1201. PubMed ID: 35621005
    [Abstract] [Full Text] [Related]

  • 7. Changes in ocular signs and symptoms in patients switching from bimatoprost-timolol to tafluprost-timolol eye drops: an open-label phase IV study.
    Bourne RRA, Kaarniranta K, Lorenz K, Traverso CE, Vuorinen J, Ropo A.
    BMJ Open; 2019 Apr 02; 9(4):e024129. PubMed ID: 30944129
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Preservative-free tafluprost/timolol fixed combination: a new opportunity in the treatment of glaucoma.
    Konstas AG, Holló G.
    Expert Opin Pharmacother; 2016 Jun 02; 17(9):1271-83. PubMed ID: 27123557
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy, safety, and tolerability of preservative-free fixed combination of tafluprost 0.0015%/timolol 0.5% versus concomitant use of the ingredients.
    Holló G, Hommer A, Antón López A, Ropo A.
    J Ocul Pharmacol Ther; 2014 Aug 02; 30(6):468-75. PubMed ID: 24738883
    [Abstract] [Full Text] [Related]

  • 13. Fixed-dose combination of tafluprost and timolol in the treatment of open-angle glaucoma and ocular hypertension: comparison with other fixed-combination products.
    Holló G, Vuorinen J, Tuominen J, Huttunen T, Ropo A, Pfeiffer N.
    Adv Ther; 2014 Sep 02; 31(9):932-44. PubMed ID: 25213118
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Preservative-free tafluprost in the treatment of open-angle glaucoma or ocular hypertension in India: a phase III clinical trial.
    Chabi A, Baranak C, Lupinacci R, Herring WJ.
    Int J Clin Pract; 2016 Jul 02; 70(7):577-86. PubMed ID: 27292765
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.